학술논문
O-3 Additional data from the KEYNOTE-859 study of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer
Document Type
Abstract
Author
Source
In Annals of Oncology June 2023 34 Supplement 1:S181-S181
Subject
Language
ISSN
0923-7534